Abstract
Fibroblast Growth Factor 21 (FGF21) regulates mainly glucose and lipid metabolism. It improves insulin sensitivity, increases high-density lipoprotein, decreases serum triglyceride, low-density lipoprotein, blood glucose level and body weight. However, high circulating FGF21 levels have been found in the case of the type 2 diabetes, chronic heart disease, non-alcoholic fatty liver disease, obesity and other. These findings may indicate the FGF21 resistance or compensatory response to the metabolic stress. Thus, serum FGF21 can be seen as a potential marker of these metabolic disorders. The purpose of this review has been to summarize the scientific date of influence FGF21 on the development of the diseases which associated with metabolic disorders.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
